Facebook
Twitter
LinkedIn
Forward
Rheumatology Association of Iowa 7th Annual Meeting
| Registration |
|---|
Cost:
Registration refund requests must be submitted in writing to the RAI Executive Office no later than March 3, 2021. All refund requests will be subject to a $5.00 processing fee. No refunds will be made after March 3, 2021. |
Target Audience
Healthcare professionals who work in Rheumatology.
Educational Need
Today’s challenging health care environment is affecting the way physicians manage their practices, interfering with access to care and forcing them to make difficult decisions. Rheumatologists need to be aware of emerging trends in practice management, payer reform, and administrative simplification of impact to the success of their practices and quality of patient care.
Objectives
- Describe the immunopathogenesis of COVID-19 and the intersection of the infection and autoimmunity.
- Recognize the challenges posed by COVID-19 in terms of society and science, clinical trial conduct and interpretation.
- Relate treatment and vaccine development to practical issues of patient care.
- Recognize changes in federal and local policies affecting practice.
- Evaluate the potential impact of new legislation on practice and payment models and be prepared to adapt.
- Identify opportunities for state and national advocacy, legislative action, and our need for representation at the state and national level.
Agenda
All sessions are taking place virtually. All times are in Central Time (US and Canada).
| 8 am | Welcome and Introductions | |
| 8:10 am | COVID-19 at 1 Year: The Good, the Bad and Ugly Leonard Calabrese, DO, Cleveland Clinic Since the beginning of the COVID pandemic 1 year ago over 100,000 articles have been published leaving clinicians and scientists challenged to critically appraise the literature. This review is an attempt to answer critical questions confronting rheumatologists in terms of patient care, education and research regarding COVID-19. | |
| 9:10 am | Industry Satellite Symposium - Safety Data By The Numbers: Exploring the Risks and Benefits of a JAK Inhibitor Therapy in Patients with Moderate to Severe RA (Non-CME) | |
| 10:10 am | Break | |
| 10:25 am | Advocacy Update Madelaine A. Feldman, MD, FACR, The Rheumatology Group | |
| 11:25 am | Iowa Legislation Update Bharat Kumar, MD, MME, FACP, RhMSU There is a lack of information on the final rules by the last administration Health and Human Services for the Most Favored Nation and Rebate rule for Seniors. There is also a lack of Information on the Passage of Competitive Health Insurance Reform Act as well as information on the issues involving the SAD (self-administered drugs) List, the CMS definition of self-administered and the implications for moving a medication to the SAD List. With physicians focused on the delivery of care, is hard to keep track of legislative and regulatory developments that will ultimately impact their provision of that care. It is important to keep us as rheumatologists informed on socioeconomic activity in Washington, as well as local governments, focusing on how new initiatives will impact their patients and practice. Rheumatologists need to be aware of federal, Iowa state and local legislation and regulations related to medication access, practice management, private payer reform and administrative simplification and its impact to the success of their practice and quality of patient care. | |
| 11:55 am | Industry Satellite Symposium: The Role of IL-6 in inflammation, RA, and Cytokine Release Syndrome Leonard Calabrese, DO, Cleveland Clinic Sponsored by Sanofi (Non-CME) | |
| 12:15 pm | Improving Recognition and Management of EGPA A Multidisciplinary Approach to Individualizing Treatment Michael E. Wechsler, National Jewish Health- Cohen Family Asthma Institute This session is accredited separately by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education; all CME information will be available onsite. | |
| 1:15 pm | Adjourn | |
Questions
RAI Executive Office
847-517-7225
rai@wjweiser.com
Leonard Calabrese, DO
Dr. Calabrese heads Cleveland Clinic's Section of Clinical Immunology and manages its Clinical Immunology Clinic. He specializes in diseases of the immune system -- in particular, immunodeficiency diseases, such as human immunodeficiency virus (HIV) and other chronic viral infections, which are the subject of both clinical care and investigation. Dr. Calabrese is also Co-director of the Center for Vasculitis Care and Research and has a particular interest in vascular inflammatory disease of the central nervous system.
A graduate of the Kansas City University of Medicine and Biosciences , Dr. Calabrese performed his internal medicine training at Cleveland Clinic in Ohio, followed by a fellowship in rheumatic and immunologic disease. He has been a staff member in Cleveland Clinic's Department of Rheumatic and Immunologic Diseases since 1980.
Recipient of numerous awards and honors, Dr. Calabrese has received an honorary Doctorate of Humane Letters from the Kansas City University of Medicine and Biosciences, the Phillips Medal of Public Service from the Ohio University College of Osteopathic Medicine, the Bruce Hubbard Stewart Award for humanitarianism and Leonard Tow Humanitarianism in Medicine award from the Arnold P Goldman MD Foundation. He holds the R.J. Fasenmeyer Chair of Clinical Immunology and is the director of the RJ Fasenmyer Center for Clinical Immunology. When he was awarded the Theodore F. Classen, DO Chair in Osteopathic Research and Education in 2008 he became the first dual-chair holder in Cleveland Clinic history.
Dr. Calabrese is a member of many professional societies, including the American Association of Immunology, Clinical Immunology Society and the International AIDS Society and the American Osler Society. He is a fellow of the American College of Rheumatology, American College of Physicians and the American College of Sports Medicine.
Dr. Calabrese has lectured nationally and internationally on the subjects of HIV, immunology and rheumatology and is the author of more than 300 published peer-reviewed articles, book chapters and reviews.
Madelaine A. Feldman, MD, FACR
Dr. Feldman is a rheumatologist in private practice with The Rheumatology Group in New Orleans, LA. She is President of the Coalition of State Rheumatology Organizations, Chair of the Alliance for Safe Biologic Medicines and past member of the American College of Rheumatology insurance subcommittee.
Dr. Feldman is a Clinical Assistant Professor of Medicine at Tulane University School of Medicine, and lectures extensively to patients, physicians, regulators, and legislators both locally and nationally, speaking before the Health subcommittee of Energy and Commerce in 2019. She has spoken and written on the drug supply channel, particularly the effect that formulary construction and utilization management tools have on pricing and access to drugs (availability & affordability).
Dr. Feldman received the Distinguished Service Award for Tulane Medical School, was named one of the Top Women in New Orleans by City Business in 2017 and is the former radio talk show host of “Driving with Dr. Mattie.”
Bharat Kumar, MD, MME, FACP, RhMSUS
Dr. Kumar is a Clinical Assistant Professor of medicine. After attending college at the University of Pennsylvania, he went to Saba University School of Medicine and completed Internal Medicine residency at the University of Kentucky. He arrived in Iowa in 2014 and completed fellowships in both rheumatology and allergy/immunology in 2017, as well as a master’s degree in medical education and certification in musculoskeletal ultrasonography. His clinical interests include the intersection of autoimmunity and immunodeficiency, musculoskeletal ultrasonography, and ocular inflammatory diseases. As the Associate Program Director for the Rheumatology Fellowship Training Program, he is also driven by a desire to improve the quality of medical education as well as the value of clinical work for both patients and practitioners. Outside of clinic, Kumar has a keen interest in medical journalism, quality improvement, and humanism, and is the Arnold P. Gold Foundation’s Humanism-in-Research Associate Editor.
Accreditation Statements
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 2.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Rheumatology Association of Iowa. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 2.5 continuing education contact hour(s). No partial credit awarded.
- Other: This live activity is designated for 2.5 AMA PRA Category 1 Credit(s)TM.
EDUCATIONAL GRANTS
No commercial interest company provided financial support for this continuing education activity.
DISCLOSURE
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to this educational activity's content, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Bogdan Cherascu, MD, MS - Activity Director and Planning Committee Member
- Lorene Harder - Activity Coordinator and Planning Committee Member
- Bharat Kumar, MD, MME, FACP, RhMSU - Speaker
Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.
- Leonard Calabrese, DO
- Consultant for Amgen, Abbvie, BMS, Genentech, Janssen, UCB, Regeneron, Myriad, GSK, Lily, Gilead, Kiniksa, Novartis
- Speaker for Abbvie, BMS, Genentech, Sanofi-Regeneron, Novartis
- Madelaine A. Feldman, MD, FACR
- Consultant for Gilead, Lilly, Merck, Samsung
Disclaimer
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 2.50 AMA PRA Category 1 Credits™
- 2.50 AOA Category 2A
- 2.50 CE Contact Hour(s)
- 2.50 IBON
Price
Cost:
- Complimentary: Member - Physician
- $50.00: Nonmember - Physician
- Complimentary: Member - Non-physician
- $25.00: Nonmember - Non-physician
- Complimentary: Student, Fellow, Resident
Registration refund requests must be submitted in writing to the RAI Executive Office no later than March 3, 2021. All refund requests will be subject to a $5.00 processing fee. No refunds will be made after March 3, 2021.